VANCOUVER, British Columbia, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQB: EUMNF; Frankfurt: E06) (the "Company" or "EMN"announces that, effective November 12, 2024 Vancouver time, Martina Blahova, the Company’s current Chief Financial Officer, has been appointed as Interim Chief Executive Officer. Ms Blahova will replace Dr. Matthew James who has resigned as Chief Executive Officer and director of the Company. Euro Manganese's Board will conduct a search for a new Chief Executive Officer.
Ms. Blahova joined Euro Manganese in 2018 as Corporate Controller and has served as Chief Financial Officer since January 2020. Prior to joining the Company, Ms. Blahova was Manager of Financial Reporting at SSR Mining Inc., a global precious metals producer. She also worked in accounting consultancy and was Manager of Financial Planning and Analysis for the Czech subsidiary of Rheinmetall Group AG, a global supplier to the automotive and defence industries. Ms. Blahova was previously at PricewaterhouseCoopers in increasingly senior roles, having worked at the firm’s Prague (CZ) and Reading (UK) offices. She received her ACCA (UK) qualification while working at the Prague office of Ernst & Young. Ms. Blahova is a Fellow Certified Chartered Accountant in the UK and a Chartered Professional Accountant (CGA) in Canada. She has a Master of Economics degree, specializing in international trade, from the University of Economics in Prague, and a Master of International Business from the Université d'Orléans, France.
- Forums
- ASX - By Stock
- James is leaving
EMN
euro manganese inc
Add to My Watchlist
0.00%
!
19.0¢

VANCOUVER, British Columbia, Nov. 13, 2024 (GLOBE NEWSWIRE) --...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.73M |
Open | High | Low | Value | Volume |
18.5¢ | 19.5¢ | 18.5¢ | $26.38K | 137.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6076 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 7645 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8232 | 0.200 |
1 | 10256 | 0.195 |
1 | 6885 | 0.180 |
1 | 10000 | 0.175 |
2 | 41394 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 588 | 1 |
0.195 | 7645 | 1 |
0.205 | 1590 | 1 |
0.210 | 50000 | 1 |
0.215 | 314 | 1 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
EMN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online